THE JELLIFYING SILVER CONTACT LAYER PROVEN TO FACILITATE WOUND PROGRESS
Patients with light to moderately exudative partial and full thickness wounds, including diabetic ulcers, first and second degree burns, decubitus ulcers, venous stasis ulcers, and graft and donor sites.
- Clinically proven to facilitate wound progress with reduced signs of local infection over neutral dressings(2)
- Shown to be effective against bacteria most frequently associated with wound infections: Staphylococcuss aureus, Streptococcuss pyogenes, Pseudomonas aeruginosa (pyocyanic bacillus), MRSA, Enterococcus faecalis VRE, Escherichia coli and Candida albicans(1)
- Sustained antibacterial activity for up to 7 days (in vitro studies)(1)
- Atraumatic and pain-free due to the jellifying TLC-Ag matrix
